Zelira in the news
Zelira Therapeutics (ASX:ZLD) launches Zenivol in Australia
Zelira Therapeutics (ZLD) proprietary cannabinoid medicine, Zenivol, can now be prescribed to patients in Australia.
This comes after the company received the Therapeutic Goods Administration’s (TGA) Special Access Scheme approval for the treatment.